Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unraveling the prevalence of various signalling pathways in non-small-cell lung cancer: a review.

Molecular and cellular biochemistry - 1 Dec 2023

Nair Aathira Sujathan, Jayan Ajay P, Anandu K R, Saiprabha V N, Pappachen Leena K

Abstract excerpt

Cancer has become a huge public health issue all around the world. The focus of research is on innovative cancer therapy techniques that include the disease's unique targets. Among the cancer-related deaths that occur, lung cancer is considered to be one of the major, accounting for about 1.6 million fatalities globally in 2012, or nearly 20% of all cancer deaths. Non-small-cell lung cancer, a type of lung cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Phosphatidylinositol 3-Kinases

Share to Prevalence

Share to Signal Transduction

Source

Identifiers

PMID: 37014561
DOI: 10.1007/s11010-023-04704-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unraveling the prevalence of various signalling pathways in non-small-cell lung cancer: a review.PMID 37014561Read ↗

Molecular target therapeutics of EGF-TKI and downstream signaling pathways in non-small cell lung cancers.Semantic proximity Read ↗

Established, emerging and elusive molecular targets in the treatment of lung cancer.Semantic proximity Read ↗

Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer.Semantic proximity Read ↗

Signal pathways and precision therapy of small-cell lung cancerSemantic proximity Read ↗

Pathogenesis of lung cancer signalling pathways: roadmap for therapies.Semantic proximity Read ↗

Novel insights into the molecular origins and treatment of lung cancer.Semantic proximity Read ↗

Non-small-cell lung cancer-associated gene mutations and inhibitorsSemantic proximity Read ↗

Targeted therapies and immunotherapy in non-small-cell lung cancerSemantic proximity Read ↗

[From rare mutations to classical ones, inhibition of signaling pathways in non-small cell lung cancer].Semantic proximity Read ↗

New Scope of Targeted Therapies in Lung Carcinoma.Semantic proximity Read ↗

Non-small-cell lung cancer.Semantic proximity Read ↗

RAS and BRAF in the foreground for non-small cell lung cancer and colorectal cancer: Similarities and main differences for prognosis and therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.